New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Women with benign breast disease face higher risk of breast cancer in the long term, according to large-scale study

Women with benign breast disease face higher risk of breast cancer in the long term, according to large-scale study

by European Organisation for Research and Treatment of CancerCumulative incidence rates of breast cancer and 95% confidence intervals in women with and without benign breast disease within year at ind
Oncology February 03,2024
Women with benign breast disease face higher risk of breast cancer in the long term, according to large-scale study

Women with benign breast disease face higher risk of breast cancer in the long term, according to large-scale study

by European Organisation for Research and Treatment of CancerCumulative incidence rates of breast cancer and 95% confidence intervals in women with and without benign breast disease within year at ind
Oncology February 03,2024
Researchers generate lab-grown human tissue model for food tube cancer

Researchers generate lab-grown human tissue model for food tube cancer

by Johns Hopkins University School of MedicineHuman gastroesophageal junction-derived organoid, modified by dual-knockout of key tumor suppressor genes (TP53/CDKN2A) using CRISPR/Cas9 gene editin
Oncology February 03,2024
Researchers generate lab-grown human tissue model for food tube cancer

Researchers generate lab-grown human tissue model for food tube cancer

by Johns Hopkins University School of MedicineHuman gastroesophageal junction-derived organoid, modified by dual-knockout of key tumor suppressor genes (TP53/CDKN2A) using CRISPR/Cas9 gene editin
Oncology February 03,2024
Researchers identify drug characteristics that make cancer metastasis therapy more effective

Researchers identify drug characteristics that make cancer metastasis therapy more effective

by Tohoku UniversityOptimal osmotic pressure and viscosity ranges for anticancer drug solvents used in lymphatic delivery (blue area). It is applicable to all types of cancer. Credit: Tohoku Univ
Oncology February 03,2024
Researchers identify drug characteristics that make cancer metastasis therapy more effective

Researchers identify drug characteristics that make cancer metastasis therapy more effective

by Tohoku UniversityOptimal osmotic pressure and viscosity ranges for anticancer drug solvents used in lymphatic delivery (blue area). It is applicable to all types of cancer. Credit: Tohoku Univ
Oncology February 03,2024
Investigators find disparities in mesothelioma survival due to social determinants, limited access

Investigators find disparities in mesothelioma survival due to social determinants, limited access

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainTreatment outcomes for patients with malignant pleural mesothelioma, a rare cancer commonly known as mesothelioma, are often af
Oncology February 03,2024
Investigators find disparities in mesothelioma survival due to social determinants, limited access

Investigators find disparities in mesothelioma survival due to social determinants, limited access

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainTreatment outcomes for patients with malignant pleural mesothelioma, a rare cancer commonly known as mesothelioma, are often af
Oncology February 03,2024
Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin
Oncology February 03,2024
Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin
Oncology February 03,2024
Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

by University of PittsburghCredit: Unsplash/CC0 Public DomainCertain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, accord
Oncology February 03,2024
Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

by University of PittsburghCredit: Unsplash/CC0 Public DomainCertain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, accord
Oncology February 03,2024
Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l
Oncology February 03,2024
Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l
Oncology February 03,2024
Study finds senescent immune cells promote lung tumor growth

Study finds senescent immune cells promote lung tumor growth

by Mayo ClinicGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.006Macrophages are a type of white blood cell that are among the body's first line of defe
Oncology February 03,2024
Study finds senescent immune cells promote lung tumor growth

Study finds senescent immune cells promote lung tumor growth

by Mayo ClinicGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.006Macrophages are a type of white blood cell that are among the body's first line of defe
Oncology February 03,2024
Treatment with immunotherapy alone produces 'exceptional' response rates in some melanoma patients

Treatment with immunotherapy alone produces 'exceptional' response rates in some melanoma patients

by Ohio State University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Data from a national clinic
Oncology February 03,2024
Treatment with immunotherapy alone produces 'exceptional' response rates in some melanoma patients

Treatment with immunotherapy alone produces 'exceptional' response rates in some melanoma patients

by Ohio State University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Data from a national clinic
Oncology February 03,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com